Opportunity ID: 362851
This opportunity is no longer listed as open or forecasted.
General Information
| Funding Opportunity Number | HT942526DMDRPCTRA |
| Funding Opportunity Title | DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award |
| Agency | Danielle Reckley Grantor |
| Document Type | synopsis |
| Version | 2 |
| Opportunity Category | Discretionary |
| Opportunity Category Explanation | Not specified |
| Funding Instrument Type | Grant |
| Category of Funding Activity | Science and Technology and other Research and Development |
| Category Explanation | Not specified |
| Expected Number of Awards | 6 |
| Cost Sharing or Matching Requirement | No |
| Posted Date | Jun 17, 2026 12:00:00 AM EDT |
| Last Updated Date | Jun 24, 2026 02:51:08 PM EDT |
| Original Closing Date | Sep 18, 2026 12:00:00 AM EDT |
| Original Closing Date Notes | Not specified |
| Current Closing Date | Sep 18, 2026 12:00:00 AM EDT |
| Current Closing Date Notes | Not specified |
| Estimated Synopsis Date | Not specified |
| Estimated Application Due Date | Not specified |
| Estimated Award Date | Not specified |
| Estimated Project Start Date | Not specified |
| Archive Date | Oct 18, 2026 12:00:00 AM EDT |
| Estimated Total Program Funding | 8,460,000 |
| Award Ceiling | none |
| Award Floor | none |
Assistance Listings
- 12.420 — Military Medical Research and Development
Eligibility
| Eligible Applicants | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
Description
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.
Distinctive Features: The FY26 CTRA offers two funding levels:
• Funding Level 1 to support smaller, less complex preclinical and/or clinical research.
• Funding Level 2 to support larger, more complex preclinical and/or clinical research.
The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories:
• Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission.
• Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field.
Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed.
Additional Information
| Contact | Danielle Reckley Grantor |
| Contact Information | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| help@eBRAP.org | |
| Email Description | eBRAP Help Desk |
| Phone | 301-619-1139 |
Additional information
Version History
Version history
| Opp hist id / Opportunity id | 362851 |
| Opp hist id / Revision | 0 |
| Opportunity id | 362851 |
| Revision | 0 |
| Opportunity number | HT942526DMDRPCTRA |
| Opportunity title | DoW Duchenne Muscular Dystrophy Clinical/Translational Award |
| Owning agency code | DOD-AMRAA |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Synopsis / Id / Opportunity id | 362851 |
| Synopsis / Id / Revision | 0 |
| Synopsis / Opportunity id | 362851 |
| Synopsis / Revision | 0 |
| Synopsis / Version | 1 |
| Synopsis / Agency code | DOD-AMRAA |
| Synopsis / Agency address desc | eBRAP Help Desk |
| Synopsis / Agency details / Code | AMRAA |
| Synopsis / Agency details / Seed | DOD-AMRAA |
| Synopsis / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Synopsis / Agency details / Agency code | DOD-AMRAA |
| Synopsis / Agency details / Top agency code | DOD |
| Synopsis / Agency contact phone | 301-619-1139 |
| Synopsis / Agency contact name | Danielle Reckley Grantor |
| Synopsis / Agency contact desc | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Synopsis / Agency contact email | help@eBRAP.org |
| Synopsis / Agency contact email desc | eBRAP Help Desk |
| Synopsis / Synopsis desc | Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.
Distinctive Features: The FY26 CTRA offers two funding levels: • Funding Level 1 to support smaller, less complex preclinical and/or clinical research. • Funding Level 2 to support larger, more complex preclinical and/or clinical research. The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories: • Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission. • Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field. Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed. |
| Synopsis / Response date | Sep 18, 2026 12:00:00 AM EDT |
| Synopsis / Response date desc | Not specified |
| Synopsis / Posting date | Jun 17, 2026 12:00:00 AM EDT |
| Synopsis / Archive date | Oct 18, 2026 12:00:00 AM EDT |
| Synopsis / Cost sharing | No |
| Synopsis / Number of awards | 6 |
| Synopsis / Estimated funding | 8460000 |
| Synopsis / Estimated funding formatted | 8,460,000 |
| Synopsis / Award ceiling | none |
| Synopsis / Award floor | none |
| Synopsis / Applicant eligibility desc | Not specified |
| Synopsis / Create time stamp | Jun 17, 2026 02:06:22 PM EDT |
| Synopsis / Action type | U |
| Synopsis / Action date | Jun 24, 2026 02:51:08 PM EDT |
| Synopsis / Created date | Jun 17, 2026 02:04:34 PM EDT |
| Synopsis / Last updated date | Jun 17, 2026 02:04:34 PM EDT |
| Synopsis / Applicant types 1 / Id | 99 |
| Synopsis / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Synopsis / Funding instruments 1 / Id | G |
| Synopsis / Funding instruments 1 / Description | Grant |
| Synopsis / Funding activity categories 1 / Id | ST |
| Synopsis / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Synopsis / Response date str | 2026-09-18-00-00-00 |
| Synopsis / Posting date str | 2026-06-17-00-00-00 |
| Synopsis / Archive date str | 2026-10-18-00-00-00 |
| Synopsis / Create time stamp str | 2026-06-17-14-06-22 |
| Cfdas 1 / Id | 434166 |
| Cfdas 1 / Opportunity id | 362851 |
| Cfdas 1 / Revision | 0 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Synopsis modified fields | Not specified |
| Forecast modified fields | Not specified |
Synopsis changes
revision
version
opportunityTitle
createTimeStamp
| Id | 362851 |
| Revision | 1 |
| Opportunity number | HT942526DMDRPCTRA |
| Opportunity title | DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award |
| Owning agency code | DOD-AMRAA |
| Modified comments | Revise FOA title |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Synopsis / Opportunity id | 362851 |
| Synopsis / Version | 2 |
| Synopsis / Agency code | DOD-AMRAA |
| Synopsis / Agency name | Danielle Reckley Grantor |
| Synopsis / Agency phone | 301-619-1139 |
| Synopsis / Agency address desc | eBRAP Help Desk |
| Synopsis / Agency details / Code | AMRAA |
| Synopsis / Agency details / Seed | DOD-AMRAA |
| Synopsis / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Synopsis / Agency details / Agency code | DOD-AMRAA |
| Synopsis / Agency details / Top agency code | DOD |
| Synopsis / Top agency details / Code | DOD |
| Synopsis / Top agency details / Seed | DOD |
| Synopsis / Top agency details / Agency name | Department of Defense |
| Synopsis / Top agency details / Agency code | DOD |
| Synopsis / Top agency details / Top agency code | DOD |
| Synopsis / Agency contact phone | 301-619-1139 |
| Synopsis / Agency contact name | Danielle Reckley Grantor |
| Synopsis / Agency contact desc | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Synopsis / Agency contact email | help@eBRAP.org |
| Synopsis / Agency contact email desc | eBRAP Help Desk |
| Synopsis / Synopsis desc | Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.
Distinctive Features: The FY26 CTRA offers two funding levels: • Funding Level 1 to support smaller, less complex preclinical and/or clinical research. • Funding Level 2 to support larger, more complex preclinical and/or clinical research. The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories: • Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission. • Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field. Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed. |
| Synopsis / Response date | Sep 18, 2026 12:00:00 AM EDT |
| Synopsis / Response date desc | Not specified |
| Synopsis / Posting date | Jun 17, 2026 12:00:00 AM EDT |
| Synopsis / Archive date | Oct 18, 2026 12:00:00 AM EDT |
| Synopsis / Cost sharing | No |
| Synopsis / Number of awards | 6 |
| Synopsis / Estimated funding | 8460000 |
| Synopsis / Estimated funding formatted | 8,460,000 |
| Synopsis / Award ceiling | none |
| Synopsis / Award floor | none |
| Synopsis / Applicant eligibility desc | Not specified |
| Synopsis / Create time stamp | Jun 24, 2026 02:51:08 PM EDT |
| Synopsis / Mod comments | Revise FOA title |
| Synopsis / Created date | Jun 17, 2026 02:04:34 PM EDT |
| Synopsis / Last updated date | Jun 24, 2026 02:51:08 PM EDT |
| Synopsis / Applicant types 1 / Id | 99 |
| Synopsis / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Synopsis / Funding instruments 1 / Id | G |
| Synopsis / Funding instruments 1 / Description | Grant |
| Synopsis / Funding activity categories 1 / Id | ST |
| Synopsis / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Synopsis / Response date str | 2026-09-18-00-00-00 |
| Synopsis / Posting date str | 2026-06-17-00-00-00 |
| Synopsis / Archive date str | 2026-10-18-00-00-00 |
| Synopsis / Create time stamp str | 2026-06-24-14-51-08 |
| Agency details / Code | AMRAA |
| Agency details / Seed | DOD-AMRAA |
| Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Agency details / Agency code | DOD-AMRAA |
| Agency details / Top agency code | DOD |
| Top agency details / Code | DOD |
| Top agency details / Seed | DOD |
| Top agency details / Agency name | Department of Defense |
| Top agency details / Agency code | DOD |
| Top agency details / Top agency code | DOD |
| Synopsis attachment folders 1 / Id | 80323 |
| Synopsis attachment folders 1 / Opportunity id | 362851 |
| Synopsis attachment folders 1 / Folder type | Full Announcement |
| Synopsis attachment folders 1 / Folder name | FY26 DMDRP CTRA |
| Synopsis attachment folders 1 / Zip lob size | 571327 |
| Synopsis attachment folders 1 / Created date | Jun 17, 2026 02:05:44 PM EDT |
| Synopsis attachment folders 1 / Last updated date | Jun 17, 2026 02:06:22 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Id | 353126 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Opportunity id | 362851 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Mime type | application/pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File name | HT9425FY26DMDRPCTRA_for GG.pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File description | FY26 DMDRP CTRA Program Announcement |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File lob size | 728572 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Created date | Jun 17, 2026 02:06:22 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Synopsis att folder id | 80323 |
| Synopsis document urls | Not specified |
| Syn att change comments | Not specified |
| Cfdas 1 / Id | 434166 |
| Cfdas 1 / Opportunity id | 362851 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Opportunity pkgs | Not specified |
| Closed opportunity pkgs 1 / Id | 293360 |
| Closed opportunity pkgs 1 / Topportunity id | 362851 |
| Closed opportunity pkgs 1 / Family id | 14 |
| Closed opportunity pkgs 1 / Dialect | XFDL2.2 |
| Closed opportunity pkgs 1 / Opportunity number | HT942526DMDRPCTRA |
| Closed opportunity pkgs 1 / Opportunity title | DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award |
| Closed opportunity pkgs 1 / Cfda number | 12.420 |
| Closed opportunity pkgs 1 / Opening date | Jun 17, 2026 12:00:00 AM EDT |
| Closed opportunity pkgs 1 / Closing date | Sep 18, 2026 12:00:00 AM EDT |
| Closed opportunity pkgs 1 / Owning agency code | DOD-AMRAA |
| Closed opportunity pkgs 1 / Program title | Military Medical Research and Development |
| Closed opportunity pkgs 1 / Contact info | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Closed opportunity pkgs 1 / Grace period | 0 |
| Closed opportunity pkgs 1 / Electronic required | Y |
| Closed opportunity pkgs 1 / Expected application count | 110 |
| Closed opportunity pkgs 1 / Expected application size | 1000000 |
| Closed opportunity pkgs 1 / Open to applicant type | 1 |
| Closed opportunity pkgs 1 / Is multi project | N |
| Closed opportunity pkgs 1 / Extension | |
| Closed opportunity pkgs 1 / Mimetype | application/pdf |
| Closed opportunity pkgs 1 / Last update | Jun 17, 2026 02:12:17 PM EDT |
| Closed opportunity pkgs 1 / Workspace compatible flag | Y |
| Closed opportunity pkgs 1 / Package id | PKG00293360 |
| Closed opportunity pkgs 1 / Opening date str | 2026-06-17-00-00-00 |
| Closed opportunity pkgs 1 / Closing date str | 2026-09-18-00-00-00 |
| Original due date | Sep 18, 2026 12:00:00 AM EDT |
| Original due date desc | Not specified |
| Synopsis modified fields | revision; version; opportunityTitle; createTimeStamp |
| Forecast modified fields | Not specified |
| Error messages | Not specified |
| Syn post date in past | Yes |
| Doc type | synopsis |
| Forecast hist count | 0 |
| Synopsis hist count | 0 |
| Assist compatible | No |
| Assist url | Not specified |
| Related opps | Not specified |
| Ost | CLOSED |
Related Documents
Packages
| Agency Contact Information: | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00293360 | Jun 17, 2026 12:00:00 AM EDT | Sep 18, 2026 12:00:00 AM EDT | View |
